| Ashland Health Center | |
| 625 South Kentucky, Ashland, Kansas 67831 | |
| (620) 635-2241 | |
| Not Available |
| Name | Ashland Health Center |
|---|---|
| Type | Critical Access Hospital |
| Location | 625 South Kentucky, Ashland, Kansas |
| Ownership | Voluntary non-profit - Other |
| Emergency Services | Yes |
| Medicare ID (CCN) | 171304 |
| NPI Number | 1265529614 |
| Organization Name | ASHLAND DISTRICT HOSPITAL |
| Address | 625 Kentucky St, Ashland, KS 67831 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 620-635-2241 |
News Archive
The Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) review has been published in the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO) to update recommendations for the safe irradiation of 16 organs. For each organ, the relationship between dose/volume and clinical outcome is reviewed. These reviews replace initial recommendations published in 1991.
Porvair Sciences has confirmed that 2016 will see record sales of its Ultravap and Minivap ranges of blowdown evaporators to laboratories worldwide. The company first began selling nitrogen blowdown evaporators for microplate sample drying in 1999.
Results released today from the Pharmacy Manpower Project's 2009 National Pharmacist Workforce Survey indicate shifts in the pharmacy profession toward more patient care. This 2009 report also provides insight into how the nation's current economic situation has influenced the dynamics of the U.S. pharmacy workforce as nearly a quarter of pharmacists are practicing part-time and more are working past retirement age. This study is the third in a series of surveys commissioned by the Pharmacy Manpower Project, Inc. (PMP) since 2000 and has been highly anticipated throughout the industry.
BIOCIUS Life Sciences Inc., developers of the RapidFire® high-throughput mass spectrometry system, and BlueSky Biotech, service provider of discovery biologicals, today announced their collaboration to offer the industry's only Sirtuin (SIRT, silent mating type information regulation homolog) enzyme preparations fully-validated in a label-free functional assay.
Exelixis, Inc. today reported interim data from an ongoing phase 1 dose-escalation trial of XL147 (SAR245408) in combination with the EGFR inhibitor erlotinib in patients with advanced solid tumors.
› Verified 7 days ago
| NPI Number | 1760415731 |
| Organization Name | ASHLAND HOSPITAL DISTRICT #3 |
| Doing Business As | ASHLAND HEALTH CENTER |
| Address | 625 Kentucky St, Ashland, KS 67831 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 620-635-2241 |
News Archive
The Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) review has been published in the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO) to update recommendations for the safe irradiation of 16 organs. For each organ, the relationship between dose/volume and clinical outcome is reviewed. These reviews replace initial recommendations published in 1991.
Porvair Sciences has confirmed that 2016 will see record sales of its Ultravap and Minivap ranges of blowdown evaporators to laboratories worldwide. The company first began selling nitrogen blowdown evaporators for microplate sample drying in 1999.
Results released today from the Pharmacy Manpower Project's 2009 National Pharmacist Workforce Survey indicate shifts in the pharmacy profession toward more patient care. This 2009 report also provides insight into how the nation's current economic situation has influenced the dynamics of the U.S. pharmacy workforce as nearly a quarter of pharmacists are practicing part-time and more are working past retirement age. This study is the third in a series of surveys commissioned by the Pharmacy Manpower Project, Inc. (PMP) since 2000 and has been highly anticipated throughout the industry.
BIOCIUS Life Sciences Inc., developers of the RapidFire® high-throughput mass spectrometry system, and BlueSky Biotech, service provider of discovery biologicals, today announced their collaboration to offer the industry's only Sirtuin (SIRT, silent mating type information regulation homolog) enzyme preparations fully-validated in a label-free functional assay.
Exelixis, Inc. today reported interim data from an ongoing phase 1 dose-escalation trial of XL147 (SAR245408) in combination with the EGFR inhibitor erlotinib in patients with advanced solid tumors.
› Verified 7 days ago
| Able to receive lab results electronically | Not Available |
| Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
The Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) review has been published in the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO) to update recommendations for the safe irradiation of 16 organs. For each organ, the relationship between dose/volume and clinical outcome is reviewed. These reviews replace initial recommendations published in 1991.
Porvair Sciences has confirmed that 2016 will see record sales of its Ultravap and Minivap ranges of blowdown evaporators to laboratories worldwide. The company first began selling nitrogen blowdown evaporators for microplate sample drying in 1999.
Results released today from the Pharmacy Manpower Project's 2009 National Pharmacist Workforce Survey indicate shifts in the pharmacy profession toward more patient care. This 2009 report also provides insight into how the nation's current economic situation has influenced the dynamics of the U.S. pharmacy workforce as nearly a quarter of pharmacists are practicing part-time and more are working past retirement age. This study is the third in a series of surveys commissioned by the Pharmacy Manpower Project, Inc. (PMP) since 2000 and has been highly anticipated throughout the industry.
BIOCIUS Life Sciences Inc., developers of the RapidFire® high-throughput mass spectrometry system, and BlueSky Biotech, service provider of discovery biologicals, today announced their collaboration to offer the industry's only Sirtuin (SIRT, silent mating type information regulation homolog) enzyme preparations fully-validated in a label-free functional assay.
Exelixis, Inc. today reported interim data from an ongoing phase 1 dose-escalation trial of XL147 (SAR245408) in combination with the EGFR inhibitor erlotinib in patients with advanced solid tumors.
› Verified 7 days ago
Ashland Health Center Critical Access Hospital Location: 625 South Kentucky, Ashland, Kansas 67831 Phone: (620) 635-2241 |